Karim A. Touijer, MD

Video

Urologic surgeon Karim Touijer – who specializes in treating prostate, bladder, and kidney cancers – discusses the comprehensive approach to cancer care at Memorial Sloan-Kettering and recent advances in minimally invasive surgery.

(01:00)

I am a surgeon who specializes in caring for patients with genitourinary cancers (prostate, kidney, bladder, testis, and adrenals). My primary interest is the development of innovative minimally invasive surgical techniques — such as laparoscopy, robotic-assisted laparoscopy, and image-guided therapies — to treat genitourinary cancers. I am an expert in the use of advanced laparoscopic surgical techniques to treat patients with urologic cancers.

The types of surgery I perform include: nerve-sparing laparoscopic or robotic radical prostatectomy (removal of the prostate) for prostate cancer; laparoscopic radical cystectomy (removal of the bladder) and urinary diversion for invasive bladder cancer; and laparoscopic partial nephrectomy (removal of the tumor only and preserving the rest of the kidney) for kidney cancers.

more…

In addition to our dedicated nursing staff, I am fortunate to have world-class colleagues from medical oncology, radiology, and radiation oncology with whom I work closely in a multidisciplinary fashion to offer the best treatment for our patients.

In my clinical research I compare minimally invasive surgery to conventional open surgery in terms of cancer control and impact on the quality of life of our patients. I am also very interested in finding ways to improve the efficacy and quality of urologic surgery and assessing its impact on surgical outcomes.

After completing a fellowship in urologic oncology and advanced laparoscopic oncology at Memorial Sloan-Kettering, I joined the Urology Service in 2004. I am board certified by the American Board of Urology, a member of the Society of Urologic Oncology, the American Urological Association, the European Association of Urology, and other national and international societies. I teach advanced laparoscopic and robotic surgery to members of the European Association of Urology and the American Association of Urology. Additionally I serve as a reviewer for a number of peer-reviewed urology and cancer journals, and lecture internationally on the role of minimally invasive surgery in treating of prostate and kidney cancers.

Location

New York City

Appointments for New Patients

646-497-9068

Phone

646-422-4486

Clinical Expertise

Urologic Oncology Prostate; Kidney Cancer; Adrenal Cancer; Minimally Invasive and Robotic Surgery; Nerve Sparing

Languages Spoken

English

Education

MD, Faculte de Medecine de Casablanca (Morocco)

Residencies

Centre Hospitalier Universitaire (Casablanca, Morocco); University of Kansas Medical Center; University of Arkansas for Medical Sciences

Fellowships

Memorial Sloan-Kettering Cancer Center

Board Certifications

Urology

See My Colleagues in:

Department of Surgery›Urology Service

Clinical Trials Co-Investigated by Karim A. Touijer

A Study of Degarelix Before Prostatectomy in Patients with Intermediate- to High-Risk Prostate Cancer

Publications by Karim A. Touijer

Visit PubMed for full listing of Karim A. Touijer journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Topics Recommended by Karim A. Touijer

Prostate Cancer: Mike’s Story

Related Multimedia See all »

Meet Urologic Surgeon Karim Touijer

cancer (KAN-ser)

A term for diseases in which abnormal cells divide without control and can invade nearby tissues. Cancer cells can also spread to other parts of the body through the blood and lymph systems. There are several main types of cancer. Carcinoma is a cancer that begins in the skin or in tissues that line or cover internal organs. Sarcoma is a cancer that begins in bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. Leukemia is a cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the blood. Lymphoma and multiple myeloma are cancers that begin in the cells of the immune system. Central nervous system cancers are cancers that begin in the tissues of the brain and spinal cord. Also called malignancy.